Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 4/20 | 0.75 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.75 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.75 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.75 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.75 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.75 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.75 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.75 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.75 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.75 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.75 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.75 |
| ▸ | TNKS | O95271 | 1/20 | 0.75 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.75 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 3/20 | 0.63 |
| ▸ | CA12 | O43570 | 2/20 | 0.63 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.63 |
| ▸ | CA2 | P00918 | 2/20 | 0.63 |
| ▸ | CA3 | P07451 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL165794 | 1.00 | HDAC2 (0.75) | HDAC2HDAC1HDAC6HCAR2HDAC3 | |
| Hydrochloric Acid SCHEMBL5066651 | 0.98 | HDAC2 (0.72) | HDAC2HDAC1HDAC6HCAR2HDAC3 | |
| Biphenyl SCHEMBL15940372 | 0.93 | HDAC2 (0.86) | HDAC2HDAC1HDAC6HCAR2HDAC3 | |
| Biphenyl SCHEMBL15940373 | 0.93 | HDAC2 (0.86) | HDAC2HDAC1HDAC6HCAR2HDAC3 | |
| SCHEMBL4946176 | 0.93 | HCAR2 (0.71) | HDAC2HDAC1HDAC6HCAR2HDAC3 | |
| SCHEMBL4946181 | 0.93 | HCAR2 (0.71) | HDAC2HDAC1HDAC6HCAR2HDAC3 | |
| Coumaric Acid SCHEMBL28454329 | 0.90 | ESR1 (0.81) | HDAC2HDAC1HDAC6HCAR2HDAC3 | |
| Coumaric Acid SCHEMBL28454328 | 0.90 | ESR1 (0.81) | HDAC2HDAC1HDAC6HCAR2HDAC3 | |
| Cinnamic Acid SCHEMBL10718535 | 0.89 | HDAC2 (0.66) | HDAC2HDAC1HDAC6HCAR2HDAC3 | |
| SCHEMBL13326884 | 0.89 | HDAC2 (0.60) | HDAC2HDAC1HDAC6HCAR2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1003 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4204514-B1 | MEDICAL DEVICE FOR VISUALLY DISPLAYING AN INJECTION PRESSURE OF A FLUID | BRAUN MELSUNGEN AG (DE) | 2025-08-06 | — | — | EP | claimed |
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | claimed |
| CN-119841755-A | Retinol derivative or its salt, and preparation method and application thereof | 深圳市护家科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-118853041-A | Preparation method and product of lithium ion energy storage battery negative electrode SBR binder | 苏州德比电子材料科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118027791-A | Weather-resistant gel coat type composite material with easily-identified characteristics | 河北多凯复合材料有限公司 | 2024-05-14 | — | — | CN | claimed |
| US-20230355883-A1 | MEDICAL DEVICE FOR VISUALLY DISPLAYING AN INJECTION PRESSURE OF A FLUID | B. BRAUN MELSUNGEN AG (DE) | 2023-11-09 | — | — | US | claimed |
| CN-114163313-B | Method for selectively synthesizing EZ-stilbene by coupling ruthenium-catalyzed aryl diazonium salt with cinnamic acid | 中山大学 | 2023-11-03 | — | — | CN | claimed |
| CN-116687962-A | Composition for preventing or treating diabetes and application thereof | 青岛大学 | 2023-09-05 | — | — | CN | claimed |
| EP-4204514-A1 | MEDICAL DEVICE FOR VISUALLY DISPLAYING AN INJECTION PRESSURE OF A FLUID | B. Braun Melsungen AG (DE) | 2023-07-05 | — | — | EP | claimed |
| CN-116157171-A | Medical device for visually indicating injection pressure of fluid | 贝朗梅尔松根股份公司 | 2023-05-23 | — | — | CN | claimed |
| US-20050107417-A1 | Medicaments for inhalation comprising a novel anticholinergic and a betamimetic | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-05-19 | — | — | US | claimed |
| WO-2005014044-A1 | MEDICAMENTS FOR INHALATION COMPRISING BETAMIMETICS AND AN ANTICHOLINERGIC | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-02-17 | — | — | WO | claimed |
| WO-2005013992-A1 | MEDICAMENTS FOR INHALATION COMPRISING BETAMIMETICS AND AN ANTICHOLINERGIC AGENT | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-02-17 | — | — | WO | claimed |
| WO-2005013945-A2 | MEDICAMENTS FOR INHALATION COMPRISING STEROIDS AND A BETAMIMETIC | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-02-17 | — | — | WO | claimed |
| US-20040010003-A1 | 9,9-dimethyl-3-oxa-9-azoniumtricyclo(3.3.1.0(2,4))nonanyl 2,2-diphenylpropionate quaternary salt | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-01-15 | — | — | US | claimed |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-10 | — | — | US | claimed |
| EP-0735062-B1 | ACTINIC-RADIATION-CURABLE COMPOSITION AND LENS SHEET | MITSUBISHI RAYON CO (JP) | 2002-01-30 | — | — | EP | claimed |
| EP-0904043-B1 | HIGH LATHER STYLING SHAMPOOS | PROCTER & GAMBLE (US) | 2000-02-02 | — | — | EP | claimed |
| EP-0859819-B1 | HEAT-ACTIVATABLE ADHESIVE COMPOSITION | MINNESOTA MINING & MFG (US) | 1999-12-29 | — | — | EP | claimed |
| US-3956168-A | QUATERNARY AMMONIUM COMPOUND | DAINIPPON INK AND CHEMICALS, INCORPORATED (JA) | 1976-05-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107417-A1 | Medicaments for inhalation comprising a novel anticholinergic and a betamimetic | CHRM1, CHRND, ADRA1D | HDAC2 2720/4885HDAC1 1701/4885HDAC6 1638/4885 |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | ADRB3, ADRB1, CHRM3 | HDAC2 3808/4885HDAC1 4225/4885HDAC6 1492/4885 |
| US-20040010003-A1 | 9,9-dimethyl-3-oxa-9-azoniumtricyclo(3.3.1.0(2,4))nonanyl 2,2-diphenylpropionate quaternary salt | ADRB1, ADRB3, ADRB2 | HDAC2 3284/4885HDAC1 2484/4885HDAC6 3396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.